We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Why Is Obesity So Common in COVID-19 Patients? New Study Sheds Light
News

Why Is Obesity So Common in COVID-19 Patients? New Study Sheds Light

Why Is Obesity So Common in COVID-19 Patients? New Study Sheds Light
News

Why Is Obesity So Common in COVID-19 Patients? New Study Sheds Light

Credit: Pixabay
Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Why Is Obesity So Common in COVID-19 Patients? New Study Sheds Light"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

A hormone that connects the body’s metabolism and immune response system may explain why COVID-19 is so dangerous for people with obesity.

“The problem for people with obesity is that their leptin levels are always high, and that can affect the response to a COVID-19 infection,” said Candida Rebello, PhD, RD, lead author of a new paper that traces the link between obesity and the virus.

The hormone leptin regulates appetite and metabolism.  Leptin also regulates the cells that fight infection. Leptin is produced by fat cells, and to a lesser extent by tissues in the lungs. The more fat a person has, the more leptin circulates in their body.

Elevated leptin levels hamper the body’s ability to fight off infections, in the lungs and elsewhere, Dr. Rebello said.  High leptin levels promote a low-grade systemic inflammatory state.

“If you have obesity, there are a number of underlying health issues that make it more difficult for you to fight off a COVID-19 infection,” said John Kirwan, PhD, Pennington Biomedical Executive Director and a co-author of the review.  “Your entire body, including your lungs, may be inflamed.  Your immune response is likely compromised, and your lung capacity reduced.

“Add in a virus that further weakens the body’s ability to fight infection, that can limit the body’s ability to control lung inflammation, and you have the recipe for disaster.”

COVID-19 vaccine developers should take the immunocompromised state resulting from obesity into consideration, in much the same way they would advancing age.

The researchers say the role of leptin in COVID-19’s development bears investigation along with the viral proteins that alter the immune systems of people with obesity.  One potential avenue of treatment may be a drug that prevents inflammatory responses to the virus.

Another potential avenue of investigation includes examining how proinflammatory fat tissue in people with obesity might contribute to activating fewer infection-fighting cells and why those cells die more quickly.

Reference:
Candida J. Rebello et al, Obesity, the most common comorbidity in SARS-CoV-2: is leptin the link?, International Journal of Obesity (2020). DOI: 10.1038/s41366-020-0640-5

This article has been republished from the following materials. Note: material may have been edited for length and content. For further information, please contact the cited source.

Advertisement